Peptides & Pharmacology
Summary
- What it is
- A comparison of two leading metabolic medications at the level of mechanism.
- Who it is for
- Anyone weighing or curious about GLP-1 era treatments.
- Evidence level
- Both are supported by large randomized trials.
- Bottom line
- Related but not identical — the right choice is individual.
Semaglutide and tirzepatide are the two names most people have heard from the modern era of metabolic medicine. They are related, they are both effective, and they are not the same drug.
Semaglutide: a GLP-1 receptor agonist
Semaglutide acts on the GLP-1 receptor — part of the system the body uses to regulate blood sugar, appetite, and the sense of fullness. By engaging that pathway, it supports glucose regulation and reduces appetite.
Tirzepatide: a dual agonist
Tirzepatide acts on the GLP-1 receptor and on a second receptor, GIP. The dual mechanism is the headline difference, and in head-to-head data it has translated into differences in degree of effect for many patients.
How to actually think about the choice
The mechanism is interesting, but it does not by itself decide anything. The right choice depends on your metabolic picture, your other conditions, how you tolerate a given medication, and practical factors. This is precisely the kind of decision that should be individualized in a clinical setting — which is why this article does not include dosing.
◆ Dr. Shusterman’s take
Patients often arrive having already decided which drug they want, based on a headline number. The number is real, but it describes an average. The honest comparison is not ‘which is stronger’ — it is ‘which is right for this person,’ and that needs a baseline and a conversation.
Related service
This topic connects to Metabolic & Weight Medicine at the practice.
Go deeper
This topic is covered in greater depth in the book, UroLongevity: What Comprehensive Longevity Medicine Offers.
Related reading
What Is Comprehensive Longevity Medicine?
The paradigm explained — and clearly separated from biohacking and anti-aging marketing.
Read ›Peptides Are Not Steroids: A Clear Explanation
Why the two are routinely confused, and what actually distinguishes them.
Read ›How to Read Medical Evidence
The single most useful skill for navigating longevity claims.
Read ›Begin with a consultation
A consultation is a conversation about your health trajectory and whether this approach fits your goals. It carries no obligation.
Book a ConsultationUroLongevity · 800 Second Avenue, 9th Floor, Suite C, New York, NY 10017